Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LISATA THERAPEUTICS, INC. Director's Dealing 2011

Dec 13, 2011

34931_dirs_2011-12-13_a803138b-b62c-42b7-9123-8549d29f3a72.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-12-09

Reporting Person: Kolbert Jason (See Remarks)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-12-09 Common Stock, $0.001 par value P 1000 $0.5568 Acquired 1000 Direct
2011-12-13 Common Stock, $0.001 par value P 1100 $0.5915 Acquired 2100 Direct
2011-12-13 Common Stock, $0.001 par value P 2900 $0.5925 Acquired 5000 Direct